The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 4, 1997, Pages 883-886

  Dizon Townson, D S ^a   Nelson, L M ^a   Jang, H ^a   Varner, M W ^a   Ward, K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

activated protein C resistance; Factor V Leiden mutation; thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; DNA;

ADULT; ARTICLE; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PREGNANCY; PRIORITY JOURNAL;

EID: 0030985282     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70615-X     Document Type: Article

References (19)

1. AM Kaunitz JM Hughes DA Grimes JC Smith RW Rochat ME Kafrissen Causes of maternal mortality in the United States Obstet Gynecol 65 1985 605 612
2. RM Bertina BPC Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
3. B Dahlback Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 1994 139 151
4. PJ Svensson B Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
5. M Kalafatis MD Rand KG Mann The mechanism of inactivation of human factor V and human factor Va by activated protein C J Biol Chem 269 1994 31869 31880
6. BM Alving PC Comp Recent advances in understanding clotting and evaluating patients with recurrent thrombosis Am J Obstet Gynecol 167 1992 1184 1191
7. J Miletich L Sherman G Broze Jr Absence of thrombosis in subjects with heterozygous protein C deficiency N Engl J Med 317 1987 991 996
8. RI Handin Inherited thrombotic disorders and antithrombotic therapy 11th ed KJ Isselbacher RD Adams E Braunwald RG Petersdorf JD Wilson Harrison's principles of internal medicine 1987 McGraw-Hill New York 1480 1483
9. M Hellgren PJ Svensson B Dahlback Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives Am J Obstet Gynecol 173 1995 210 213
10. G Cook ID Walker F McCall JA Conkie IA Greer Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy Br J Haematol 87 1994 873 875
11. JP Vandenbroucke T Koster E Briet PH Reitsma RM Bertina FR Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457
12. V De Stefano S Mastrangelo K Paciaroni H Iceland DA Lane P Scirpa Thrombotic risk during pregnancy and puerperium in women with APC-resistance-effective subcutaneous heparin prophylaxis in a pregnant patient [letter] Thromb Haemost 74 1995 793 794
13. J Bonnar Venous thromboembolism and pregnancy Clin Obstet Gynecol 8 1981 455 473
14. MJ Rothbard D Gluck ML Stone Anticoagulation therapy in antepartum pulmonary embolism N Y State J Med 76 1976 582 584
15. U Villasanta Thromboembolic disease in pregnancy Am J Obstet Gynecol 93 1965 142 160
16. A Bergqvist D Bergqvist T Hallbook Acute deep venous thrombosis (DVT) after cesarean section Acta Obstet Gynecol Scand 58 1979 473 476
17. EA Letsky Coagulation problems during pregnancy T Lind Current review in obstetrics and gynecology 1985 Churchill Livingstone Edinburgh 29 55
18. RK Laros LS Alger Thromboembolism and pregnancy Clin Obstet Gynecol 22 1979 871 888
19. C Carter M Gent JR LeClerc The epidemiology of venous thrombosis RW Colman J Hirsch VJ Marder EW Salzman Hemostasis and thrombosis: basic principles and clinical practice 1987 Lippincott Philadelphia 1185 1198